These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21418297)

  • 1. History and recent progress in evaluation of the fucosylated alpha-fetoprotein fraction.
    Aoyagi Y; Tamura Y; Suda T
    J Gastroenterol Hepatol; 2011 Apr; 26(4):615-6. PubMed ID: 21418297
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical significance of the highly sensitive fucosylated fraction of α-fetoprotein in patients with chronic liver disease.
    Hanaoka T; Sato S; Tobita H; Miyake T; Ishihara S; Akagi S; Amano Y; Kinoshita Y
    J Gastroenterol Hepatol; 2011 Apr; 26(4):739-44. PubMed ID: 21083609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an antibody-lectin enzyme immunoassay for fucosylated α-fetoprotein.
    Korekane H; Hasegawa T; Matsumoto A; Kinoshita N; Miyoshi E; Taniguchi N
    Biochim Biophys Acta; 2012 Sep; 1820(9):1405-11. PubMed ID: 22233759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fucosylated alpha-fetoprotein as marker of early hepatocellular carcinoma.
    Aoyagi Y; Isemura M; Suzuki Y; Sekine C; Soga K; Ozaki T; Ichida F
    Lancet; 1985 Dec; 2(8468):1353-4. PubMed ID: 2415789
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison between alpha-fetoprotein and p53 antibodies in the diagnosis of hepatocellular carcinoma.
    Edis C; Kähler C; Klotz W; Herold M; Feichtinger H; Königsreiner A; Margreiter R; Jaschke W; Vogel W
    Transplant Proc; 1998 May; 30(3):780-1. PubMed ID: 9595095
    [No Abstract]   [Full Text] [Related]  

  • 6. Alpha-fetoprotein in hepatocellular carcinoma surveillance: wake not the dead.
    Giannini EG; Farinati F; Trevisani F
    Hepatology; 2011 Jul; 54(1):376-7. PubMed ID: 21710475
    [No Abstract]   [Full Text] [Related]  

  • 7. Alpha-fetoprotein in early hepatocellular carcinoma.
    Marrero JA; Feng Z
    Gastroenterology; 2010 Jan; 138(1):400-1. PubMed ID: 19932214
    [No Abstract]   [Full Text] [Related]  

  • 8. The Updated Model: An Adjusted Serum Alpha-Fetoprotein-Based Algorithm for Hepatocellular Carcinoma Detection With Hepatitis C Virus-Related Cirrhosis.
    White DL; Richardson P; Tayoub N; Davila JA; Kanwal F; El-Serag HB
    Gastroenterology; 2015 Dec; 149(7):1986-7. PubMed ID: 26519622
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatocellular carcinoma (HCC) and diagnostic significance of A-fetoprotein (AFP).
    Baig JA; Alam JM; Mahmood SR; Baig M; Shaheen R; Sultana I; Waheed A
    J Ayub Med Coll Abbottabad; 2009; 21(1):72-5. PubMed ID: 20364746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum tests for diagnosis and follow-up of hepatocellular carcinoma after treatment.
    Trojan J; Raedle J; Zeuzem S
    Digestion; 1998 Jul; 59 Suppl 2():72-4. PubMed ID: 9718428
    [No Abstract]   [Full Text] [Related]  

  • 11. Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders.
    Wong RJ; Ahmed A; Gish RG
    Clin Liver Dis; 2015 May; 19(2):309-23. PubMed ID: 25921665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lectin-affinity electrophoresis for the detection of AFP microheterogeneities in patients with hepatocellular carcinoma.
    Zaninotto M; Ujka F; Lachin M; Bernardi D; Marafi C; Farinati F; Plebani M
    Anticancer Res; 1996; 16(1):305-9. PubMed ID: 8615626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-fetoprotein variants and their clinical significance.
    Xu KL; Yu EX; Lu LN; Zhou J
    Chin Med J (Engl); 1984 Jul; 97(7):538-41. PubMed ID: 6084582
    [No Abstract]   [Full Text] [Related]  

  • 14. Extremely High Preoperative Alpha-Fetoprotein Level Is Associated with Vascular Invasion, Non-R0 Resection, and Poor Prognosis in Hepatocellular Carcinoma Patients.
    Zhang Y; Huang P; Zheng Y; Wang Y; Yuan Y; He W; Liu W; Yang Z; Wang C; Yuan Y; Li B
    Am Surg; 2019 Jun; 85(6):e309-e312. PubMed ID: 31267923
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor Markers AFP, AFP-L3, and DCP in Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization.
    Hiraoka A; Ishimaru Y; Kawasaki H; Aibiki T; Okudaira T; Toshimori A; Kawamura T; Yamago H; Nakahara H; Suga Y; Azemoto N; Miyata H; Miyamoto Y; Ninomiya T; Hirooka M; Abe M; Matsuura B; Hiasa Y; Michitaka K
    Oncology; 2015; 89(3):167-74. PubMed ID: 25999038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-fetoprotein: a controversial prognostic biomarker for small hepatocellular carcinoma.
    Asrih M; Lenglet S; Mach F; Montecucco F
    World J Gastroenterol; 2013 Jan; 19(3):328-30. PubMed ID: 23372353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous drastic reduction of alpha-fetoprotein in hepatocellular carcinoma.
    Phadke AY; Desai HG
    Indian J Gastroenterol; 1996 Jul; 15(3):111. PubMed ID: 8840646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fucosylated fraction of alpha-fetoprotein as a serological marker of early hepatocellular carcinoma.
    Moriya S; Morimoto M; Numata K; Nozaki A; Shimoyama Y; Kondo M; Nakano M; Maeda S; Tanaka K
    Anticancer Res; 2013 Mar; 33(3):997-1001. PubMed ID: 23482772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Focus on a new assay of fucosylated alpha-fetoprotein and evaluation in the biological diagnosis of hepatocellular carcinoma in cirrhosis].
    Denis I; Beaudonnet A; Pichot J; Roubille M; Gelineau M
    Ann Biol Clin (Paris); 2000; 58(1):85-90. PubMed ID: 10673618
    [No Abstract]   [Full Text] [Related]  

  • 20. Settling the "score" with liver cancer.
    Koh C; Liang TJ
    J Hepatol; 2009 Jan; 50(1):7-9. PubMed ID: 19014877
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.